Read Summary

New York Lymphoma Rounds: Marginal Zone Edition

This special edition of Lymphoma Rounds will feature case presentations on Marginal Zone lymphoma, and will be held in conjunction with the Foundation’s Marginal Zone Lymphoma Scientific Workshop

Marriott East Side Hotel (click here for directions)
525 Lexington Avenue at East 49th St.
New York, NY 10017

Wednesday, April 17, 2019
6:00 PM – 9:00 PM


This program is free for healthcare professionals; however, pre-registration is required. Food and refreshments will be provided for all registered participants.

Please note: Only representatives from supporting pharmaceutical companies are invited to register. If your company is interested in becoming a Lymphoma Rounds supporter please contact Piper Harmon, LRF, at  Exhibit opportunities are also available, however, space is limited.

Companies that have secured a national exhibit sponsorship for Lymphoma Rounds must still rsvp by emailing Piper Harmon ( at least one week before the program to confirm their attendance. Otherwise, an exhibit table will not be guaranteed.


The Lymphoma Research Foundation’s New York Lymphoma Rounds program provides a forum for healthcare professionals to meet on a regular basis and address issues specific to the diagnosis and treatment of their lymphoma patients. Participants will network, share best practices and learn the latest information on new therapies and advances in the management of lymphoma through interactive case studies presented by lymphoma experts in the Greater New York City area.

At the conclusion of this educational activity, the participant should be better able to:

    • Summarize the latest developments in lymphoma diagnosis, treatment and management.
    • Apply best practices for treating lymphoma patients.
    • Inform patients about potential clinical trial opportunities.
    • Establish a network of health care professionals who work with lymphoma patients.
    Other dates in the 2018-19 New York Rounds series:

    • Wednesday, April 17, 2019

    New York Lymphoma Rounds Steering Committee

    Columbia University Medical Center
    Owen O’Connor, MD, PhD
    Francesca Montanari, MD
    Hackensack University Medical Center
    Andre Goy, MD, MS
    Icahn School of Medicine at Mount Sinai
    Joshua Brody, MD
    Memorial Sloan Kettering Cancer Center
    Anthony Mato, MD, MSCE
    David Straus, MD (chair)
    NYU Langone Medical Center
    Catherine Diefenbach, MD
    Rutgers Cancer Institute of New Jersey
    Joseph Bertino, MD
    Andrew Evens, DO, MSc, FACP
    Weill Cornell Medicine
    Koen van Besien, MD, PhD
    Ethel Cesarman, MD, PhD
    Amy Chadburn, MD
    Morton Coleman, MD

    Joint Providership Statement

    This activity has been planned and implemented in accordance with the Accreditation Requirements and Policies of the Accreditation Council for Continuing Medical Education through the joint providership of the University of Nebraska Medical Center, Center for Continuing Education and the Lymphoma Research Foundation.

    Accreditation Statement

    The University of Nebraska Medical Center, Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

    Credit Statement

    The University of Nebraska Medical Center, Center for Continuing Education designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit (s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

    Lymphoma Research Foundation and the University of Nebraska Medical Center, Center for Continuing Education

    This activity is supported by educational grants from:

    AbbVie Inc., Celgene Corporation, Genentech, Novartis, Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., Seattle Genetics, Inc., TG Therapeutics, Inc. and Verastem Oncology

Great Debates & Updates in Hematologic Malignancies

The Great Debates & Updates in Hematologic Malignancies meeting series is fast-approaching. In this 2-day, debate-style series, nationally recognized thought leaders take opposing sides on clinical—and sometimes controversial—topics currently disrupting the practice of hematology and oncology. Through comprehensive review of the latest clinical advancements in hematologic malignancies, robust audience engagement, and ample discussion, participants will leave equipped with practical implications and applications to put into practice immediately. Now located in two cities, the west coast meeting will take place in Los Angeles on March 22-23, with its east coast edition being held in New York City on April 5-6. Visit for details and use code “ENDORSER” for $50 off registration.

Print Friendly, PDF & Email